« Investor returns should be PSU banks’ mantra: Study
IHCL which runs Taj hotels plans Rs 1,800-cr expansion »

Sick bulk drug cos may get life support

The government would take measures to revive bulk drug units that have either closed down or suspended manufacturing due to short supply of raw material from China.

US FDA backs Pfizer osteoporosis drug
Orchid gets USFDA nod for non-antibiotic drug
Pharma cos demand 20% raise in prices
Pharma cos demand 20% raise in prices
Indian drug cos eye US’ Par Pharma

This entry was posted on Saturday, August 16th, 2008 at 5:04 pm and is filed under Indian Stock News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply